Molecular therapy for Cancer: NRF2 increases miRNA biogenesis and promotes tumor regression via up regulation of its target gene, 4/November/2014, 21.55

Becoming Centenarians: a myth or reality: The curcumin analogue EF24 may increase longevity via up regulation of autophagy enhancer Beclin-1, 4/November/2014, 21.00
November 4, 2014
Therapeutic insights into increasing the life expectancy of Individuals: Argonaute-2 (ago-2) increases the expression of longevity-promoting gene Sirtuin-1 via down regulation of its target gene, 4/November/2014, 22.20
November 4, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  Molecular therapy for Cancer: NRF2 increases miRNA biogenesis and promotes tumor regression via up regulation of its target gene, 4/November/2014, 21.55,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: NRF2, by up regulating the expression of its target gene, it may promote miRNA biogenesis. Thereby, it may inhibit cancer development. Together, this study suggests, for the first time, that (1) NRF2 may augment the production of small RNAs; and (2) pharmacological formulations encompassing “NRF2 activators” may inhibit cancer development by turning on the expression of tumor suppressor miRNAs.

Comments are closed.